Genome sequencing of Covid-19 samples has not discovered any new coronavirus pressure behind the an infection across the AMU campus, college authorities mentioned Sunday as one other member of their fraternity died. Professor Abu Qamar, 75, the previous dean of the College of Medication within the Jawaharlal Nehru Medical School and Hospital died right here on Sunday of Covid-19 after battling it for practically three weeks, JNMC Principal Shahid Ali Siddiqui mentioned.
Prof Qamar died two days after AMU’s former proctor, Prof Nasim Beg, 76, died in a New Delhi hospital the place he was shifted to and admitted after his situation worsened right here, his relations mentioned.
Not less than 38 AMU academics, together with 21 serving ones, have died of Covid or Covid-like signs within the final one month, triggering doubts if any new lethal pressure of the virus has been in circulation on the AMU campus.
These doubts additionally prompted the varsity’s JNMC authorities to ship Covid-19 samples from the AMU campus and its neighbouring Civil Strains space for genome sequencing to the CSIR-Institute of Genomics and Integrative Biology in New Delhi.
No new pressure of coronavirus has been detected in samples despatched for genome sequencing to the CSIR in New Delhi, mentioned a senior JNMC official, in a reduction to the hospital’s beleaguered employees who’ve been on the sting following a lot of deaths of the serving and retired AMU workers.
Prof Haris Manzoor Khan, the pinnacle of the JNMC’s Division of Microbiology and the principal investigator of the AMU’s Viral Analysis and Diagnostic Laboratory, mentioned out of the 20 samples despatched to CSIR for genome sequencing, 18 (90 %) had B.1.617.2 lineage known as the double mutation variant, first recognized in Maharashtra on October 5, 2020.
It’s a subtype of B.1.617 variant which is the principle virus circulating within the second wave of COVID-19 in Uttar Pradesh, he added.
The WHO has described it as a Variant of Concern due to its larger transmissibility and lowered neutralization from pre-existing antibodies, he mentioned.
B.1.617 has a better development fee than different circulating variants suggesting a probably elevated fee of transmission.